HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Recruiting · NCT07296341 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors | Locally Advanced or Metastatic Pancreatic Cancer With | Recruiting | Phase 1 / Phase 2 | 2026-01-14 | NCT07296341 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital, Chinese Academy of Medical Sciences | Beijing | China | 11 |